Periodic Reporting for period 1 - RSVTriVax (Development of a trivalent epitope-focused RSV vaccine to boost pre-existing immunity)

The development of an RSV vaccine is deemed a global health priority by the World Health Organization. Several decades of intensive research by both academic and private stakeholders are yet to deliver a clinically approved vaccine. Globally, RSV causes on the order of 33...